Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A critical view on sample preparation for the analysis of microplastics from stormwater retention ponds.

Journal of hazardous materials·2026

Same author

The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.

Atherosclerosis·2024

Same author

Estimating the prevalence of mental disorders in patients with newly diagnosed cancer in relation to socioeconomic status: a multicenter prospective observational study.

ESMO open·2024

Same author

Oral anticoagulant therapy in older adults.

Thrombosis research·2024

Same author

An analytical strategy for challenging members of the microplastic family: Particles from anti-corrosion coatings.

Journal of hazardous materials·2024

Same author

Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis.

International journal of pharmaceutics·2022

Search research articles

Related Experiment Videos

[Lamotrigine and the skin].

A E Rätz Bravo¹, T Zimmermann, M Haschke

¹Abteilung für klinische Pharmakologie und Toxikologie und Regionales Pharmacovigilance-Zentrum Basel, Universitätsspital Basel. raetza@uhbs.ch

|March 18, 2010

Summary

A patient experienced a reversible macular rash after starting lamotrigine (LTG) for depression and personality disorder. This case highlights LTG safety, skin reaction risks, and potential for controlled re-challenge in managing LTG-induced rashes.

Area of Science:

Pharmacology
Dermatology
Psychiatry

Background:

Lamotrigine (LTG) is an anticonvulsant and mood stabilizer used in treating epilepsy and bipolar disorder.
Adverse skin reactions are a known concern with lamotrigine, ranging from mild rashes to severe, life-threatening conditions.
Understanding risk factors and management strategies is crucial for safe lamotrigine prescribing.

Observation:

A patient with personality disorder and depression developed a macular rash 10 days after initiating lamotrigine therapy.
The rash was characterized as reversible, suggesting a potential drug-induced etiology.
This clinical presentation prompted an evaluation of lamotrigine's dermatological safety profile.

Findings:

The patient's rash resolved upon discontinuation of lamotrigine, indicating a probable drug-related adverse event.

Related Experiment Videos

Analysis of lamotrigine's safety profile reveals specific risk factors predisposing to skin reactions.

The case supports the possibility of controlled re-exposure in patients who experience benign lamotrigine-associated rashes.

Implications:

This case underscores the importance of vigilant monitoring for skin reactions during lamotrigine treatment.
It provides insights into managing lamotrigine-induced skin reactions and reducing associated risks.
The findings suggest that careful patient selection and monitoring may allow for the safe reintroduction of lamotrigine in select cases.